Sponsor franchise
REVIVA PHARMACEUTICALS
Grouping established from the issuer name.
Vehicles launched
1
0 still live
Capital raised
$34.6M
aggregate IPO proceeds
Trust under management
—
in live vehicles
Deals closed
1
0 liquidated
Completion rate
100%
of 1 resolved
Vehicles
Every SPAC attributed to REVIVA PHARMACEUTICALS, newest IPO first.
- Completed
- Trust
- $34.6M
- Per share
- $15.30
- IPO
- Aug 2018
- Deadline
- —